Analystreport

La Jolla Pharmaceutical (NASDAQ: LJPC) had its price target lowered by analysts at HC Wainwright to $25.00. They now have a "buy" rating on the stock.

La Jolla Pharmaceutical Company  (LJPC) 
Last la jolla pharmaceutical company earnings: 3/2 08:30 am Check Earnings Report
US:NASDAQ Investor Relations: lajollapharmaceutical.com/investor-relations